NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis $1.66 0.00 (0.00%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$1.73 +0.07 (+4.28%) As of 10/2/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOwnershipSEC Filings About Intelligent Bio Solutions Stock (NASDAQ:INBS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INBS alerts:Sign Up Key Stats Today's Range$1.64▼$1.7550-Day Range$1.55▼$3.3752-Week Range$1.52▼$24.90Volume42,966 shsAverage Volume42,785 shsMarket Capitalization$5.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Intelligent Bio Solutions Inc. is a life sciences company focused on non-invasive diagnostic and drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a fingerprint to identify drug metabolites. The system is designed to provide rapid, portable testing without blood or urine collection. It is intended for use by organizations such as employers, law enforcement agencies, drug-treatment providers, and other institutions that require convenient drug screening and monitoring. The company’s technology originated with Intelligent Fingerprinting, a United Kingdom-based developer that was acquired by Intelligent Bio Solutions. Intelligent Bio Solutions, formerly known as GBS Inc., has pursued commercialization of the fingerprint-based testing platform in markets including the United States, the United Kingdom, Australia, and other international regions.AI Generated. May Contain Errors. Read More Intelligent Bio Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScoreINBS MarketRank™: Intelligent Bio Solutions scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingIntelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageIntelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.Read more about Intelligent Bio Solutions' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($5.18) to ($4.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Intelligent Bio Solutions is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Intelligent Bio Solutions is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Intelligent Bio Solutions' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.65% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 0.22, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 255.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search InterestOnly 2 people have searched for INBS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows2 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by Insiders1.27% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by Institutions32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INBS Stock News HeadlinesIntelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest UpdateSeptember 26, 2026 | americanbankingnews.comIntelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System TranscriptSeptember 24, 2026 | seekingalpha.comWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it. Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge.October 4 at 1:00 AM | Paradigm Press (Ad)Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ETSeptember 10, 2026 | globenewswire.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | finanznachrichten.deIntelligent Bio Solutions Seeks FDA Clearance For Fingerprint-Based Drug Screening SystemSeptember 9, 2026 | rttnews.comIntelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | globenewswire.comIntelligent Bio Solutions Secures $5M Funding As Drug Screening System Nears FDA FilingSeptember 1, 2026 | rttnews.comSee More Headlines INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed this year? Intelligent Bio Solutions' stock was trading at $9.53 at the beginning of the year. Since then, INBS shares have decreased by 82.6% and is now trading at $1.66. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced its quarterly earnings data on Wednesday, August, 19th. The company reported ($0.90) EPS for the quarter, beating analysts' consensus estimates of ($1.58) by $0.68. The firm had revenue of $1.15 million for the quarter, compared to analyst estimates of $1.22 million. Intelligent Bio Solutions had a negative net margin of 294.88% and a negative trailing twelve-month return on equity of 175.35%. When did Intelligent Bio Solutions' stock split? Intelligent Bio Solutions's stock reverse split on Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. When did Intelligent Bio Solutions IPO? Intelligent Bio Solutions (INBS) raised $22 million in an IPO on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Intelligent Bio Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL). Company Calendar Last Earnings8/19/2026Today10/04/2026Next Earnings (Estimated)11/11/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 INBS's financial health is in the Green zone, according to TradeSmith. INBS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:INBS Previous SymbolNASDAQ:GBS CIK1725430 Webwww.ibs.inc Phone(646) 790-5756FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)($9.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.43 million Net Margins-294.88% Pretax Margin-295.82% Return on Equity-175.35% Return on Assets-91.25% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.35 Sales & Book Value Annual Sales$4.22 million Price / Sales1.31 Cash FlowN/A Price / Cash FlowN/A Book Value$2.21 per share Price / Book0.75Miscellaneous Outstanding Shares3,320,000Free Float3,275,000Market Cap$5.51 million OptionableNot Optionable Beta4.31 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:INBS) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INBS Stock Alerts